21st Century Oncology, In Collaboration With UCLA And Stanford, Recognized With “Best of Astro” Award

world news, trump, u.s., business news, stock market, entertainment news, business news, company news, market, commodities, commodity, Africa news

Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]

SOURCE 21st Century Oncology

Award Recognizes Top 10 Research Abstracts at Annual Meeting

FORT MYERS, Fla., Nov. 9, 2018 /PRNewswire/ — Research conducted by 21st Century Oncology, in collaboration with UCLA, Stanford, and other esteemed cancer research centers, was selected for a “Best of ASTRO” award, which recognizes the top 10 research submissions. The abstract titled, “Long-Term Outcomes of Stereotactic Body Radiation Therapy for Low – and Intermediate-Risk Prostate Adenocarcinoma: A Multi-Institutional Consortium Study,” was presented by Dr. Amar U. Kishan, a resident at UCLA, at the 2018 ASTRO (American Society for Radiation Oncology) Annual Meeting in San Antonio, TX on Oct. 22.

Prostate SBRT (Stereotactic Body Radiation Therapy) is a recent and highly advanced method of radiation therapy that delivers a curative radiation dose to the prostate over a short-term treatment period of five visits.

21st Century Oncology was among the very first treatment centers internationally to treat patients using this technology in 2002. Since then, 21st Century Oncology has enrolled hundreds of patients into this research study and has published results that demonstrate high rates of cure with very few or serious side effects.

“I am very proud of our research efforts at 21st Century Oncology,” said Dr. Constantine Mantz, M.D., Chief Policy Officer, 21st Century Oncology “We can now offer this treatment as a standard of care for selected patients with early-stage prostate cancer.”

Constantine Mantz, M.D. was the contributing 21st Century Oncology physician in conjunction with Amar U. Kishan,M.D.; Alan J. Katz, M.D.; Fang-I Chu, Ph.D.; Limor Appelbaum, M.D.; and Andrew Loblaw, M.D., F.R.C.P.C, M.Sc.

About 21st Century Oncology
21st Century Oncology is the largest global, provider of Integrated Cancer Care services that strongly believes in fighting for patients like an army and caring for them like a family. Operating as one dream team in the crusade against cancer, the company employs or is affiliated with more than 937 physicians globally to deliver the most advanced, integrated, and compassionate cancer care in personal and convenient settings. Headquartered in Fort Myers, FL, 21st Century Oncology operates 169 treatment centers, including 133 centers located in 16 U.S. states. In addition, the company operates 36 centers located in eight countries in Latin America. For more information, please visit https://www.21co.com/.

Media Contact: Samantha Scott, APR
(239) 221-2858 | [email protected]

Cision View original content:http://www.prnewswire.com/news-releases/21st-century-oncology-in-collaboration-with-ucla-and-stanford-recognized-with-best-of-astro-award-300747512.html

©2017 PR Newswire. All Rights Reserved.